Comparative clinical effects of hydromorphone and morphine: a meta-analysis - PubMed (original) (raw)
Meta-Analysis
. 2011 Sep;107(3):319-28.
doi: 10.1093/bja/aer232. Epub 2011 Aug 5.
Affiliations
- PMID: 21841049
- DOI: 10.1093/bja/aer232
Free article
Meta-Analysis
Comparative clinical effects of hydromorphone and morphine: a meta-analysis
L Felden et al. Br J Anaesth. 2011 Sep.
Free article
Abstract
We have conducted a meta-analysis of the clinical effects of morphine and hydromorphone to compare their benefit in analgesia. Embase and Medline were searched with an end-date of June 2009 for randomized, controlled trials or observational studies that addressed comparative analgesic and side-effects or particular side-effects. Two researchers independently identified included studies and extracted the data. Estimates of opioid effects were combined by using a random-effects model. Meta-analysis of eight studies suggested that hydromorphone (494 patients) provides slightly better (P=0.012) clinical analgesia than morphine (510 patients). The effect-size was small (Cohen's d=0.266) and disappeared when one study was removed, although the advantage of hydromorphone was more evident in studies of better quality (Jadad's rating). Side-effects were similar, for example, nausea (P=0.383, nine studies, 456 patients receiving hydromorphone and 460 morphine); vomiting (P=0.306, six studies, 246 patients receiving hydromorphone and 239 morphine); or itching (P=0.249, eight studies, 405 patients receiving hydromorphone, 410 morphine). This suggests some advantage of hydromorphone over morphine for analgesia. Additional potential clinical pharmacological advantages with regard to side-effects, such as safety in renal failure or during acute analgesia titration, are based on limited evidence and require substantiation by further studies.
Similar articles
- Satisfactory analgesia with minimal emesis in day surgeries: a randomised controlled trial of morphine versus hydromorphone.
Shanthanna H, Paul J, Lovrics P, Vanniyasingam T, Devereaux PJ, Bhandari M, Thabane L. Shanthanna H, et al. Br J Anaesth. 2019 Jun;122(6):e107-e113. doi: 10.1016/j.bja.2019.03.036. Epub 2019 Apr 23. Br J Anaesth. 2019. PMID: 31027915 Clinical Trial. - Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
Chang AK, Bijur PE, Baccelieri A, Gallagher EJ. Chang AK, et al. Am J Geriatr Pharmacother. 2009 Feb;7(1):1-10. doi: 10.1016/j.amjopharm.2009.02.002. Am J Geriatr Pharmacother. 2009. PMID: 19281935 Clinical Trial. - Satisfactory Analgesia with Minimal Emesis in Day Surgeries (SAME DayS): a protocol for a randomised controlled trial of morphine versus hydromorphone.
Shanthanna H, Paul J, Lovrics P, Devereaux PJ, Bhandari M, Thabane L. Shanthanna H, et al. BMJ Open. 2018 Jun 22;8(6):e022504. doi: 10.1136/bmjopen-2018-022504. BMJ Open. 2018. PMID: 29934395 Free PMC article. - Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P. Pergolizzi J, et al. Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626 - Gastrointestinal adverse effects associated with the use of intravenous oliceridine compared with intravenous hydromorphone or fentanyl in acute pain management utilizing adjusted indirect treatment comparison methods.
Biskupiak J, Oderda G, Brixner D, Wandstrat TL. Biskupiak J, et al. J Comp Eff Res. 2024 May;13(5):e230041. doi: 10.57264/cer-2023-0041. Epub 2024 Mar 18. J Comp Eff Res. 2024. PMID: 38497192 Free PMC article. Review.
Cited by
- The effect of two different doses of dexmedetomidine to prevent emergence agitation in children undergoing adenotonsillectomy: a randomized controlled trial.
Yi W, Li J, Zhuang Y, Wan L, Li W, Jia J. Yi W, et al. Braz J Anesthesiol. 2022 Jan-Feb;72(1):63-68. doi: 10.1016/j.bjane.2021.08.019. Epub 2021 Oct 8. Braz J Anesthesiol. 2022. PMID: 34627829 Free PMC article. Clinical Trial. - Prospective investigation of intravenous patient-controlled analgesia with hydromorphone or sufentanil: impact on mood, opioid adverse effects, and recovery.
Yang Y, Wu J, Li H, Ye S, Xu X, Cheng L, Zhu L, Peng Z, Feng Z. Yang Y, et al. BMC Anesthesiol. 2018 Apr 10;18(1):37. doi: 10.1186/s12871-018-0500-1. BMC Anesthesiol. 2018. PMID: 29636011 Free PMC article. Clinical Trial. - Hydromorphone Prescription for Pain in Children-What Place in Clinical Practice?
Rodieux F, Ivanyuk A, Besson M, Desmeules J, Samer CF. Rodieux F, et al. Front Pediatr. 2022 Apr 25;10:842454. doi: 10.3389/fped.2022.842454. eCollection 2022. Front Pediatr. 2022. PMID: 35547539 Free PMC article. Review. - Postoperative pain management in patients with chronic kidney disease.
Tawfic QA, Bellingham G. Tawfic QA, et al. J Anaesthesiol Clin Pharmacol. 2015 Jan-Mar;31(1):6-13. doi: 10.4103/0970-9185.150518. J Anaesthesiol Clin Pharmacol. 2015. PMID: 25788766 Free PMC article. Review. - Effects of patient-controlled analgesia with hydromorphone or sufentanil on postoperative pulmonary complications in patients undergoing thoracic surgery: a quasi-experimental study.
Yan G, Chen J, Yang G, Duan G, Du Z, Yu Z, Peng J, Liao W, Li H. Yan G, et al. BMC Anesthesiol. 2018 Dec 19;18(1):192. doi: 10.1186/s12871-018-0657-7. BMC Anesthesiol. 2018. PMID: 30567490 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources